Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

Hyponatremia with Neurological Symptom in Patients with Chronic Schizophrenia : Five Cases

Cho GH, Chung YC, Lim ES

  • KMID: 1512823
  • Korean J Psychopharmacol.
  • 2007 Mar;18(2):110-117.
Hyponatremia frequently occurs in patients with chronic schizophrenia and has various causes such as compulsive drinking, neuroleptics, and physical illness. If not corrected immediately, it leads to severe problems such...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two-Year Rehospitalization Rates of First Episode Schizophrenic Inpatients Discharged on Antipsychotic Medication : A Preliminary Study

Woo YS, Yook DH, Seo HJ, Chae JH, Jun TY, Bahk WM

  • KMID: 1512820
  • Korean J Psychopharmacol.
  • 2007 Mar;18(2):86-91.
OBJECTIVE: We compared the rehospitalization rate of first-episode schizophrenic inpatients who were discharged from a university hospital while being treated with risperidone, olanzapine, quetiapine, or the conventional antipsychotic haloperidol. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Body Mass Index(BMI) Changes during Combination Therapy with Mood Stabilizers and Antipsychotics in Acute Mania

Jun JS, Kim JY, Shin YB, Kim CE, Lee JS, Bae JN, Kang MH

  • KMID: 1512822
  • Korean J Psychopharmacol.
  • 2007 Mar;18(2):103-109.
OBJECTIVE: To estimate changes in body mass index (BMI) during the treatment of acute manic patients, we retrospectively analyzed the medical records of patients admitted to Inha University Medical Center...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Assessment of Abdominal Fat and Mid-Thigh Low-Density Muscle Areas in Patients with Schizophrenia

Kim CS, Nam YY, Park JS, Kim HJ, Noh TW, Nam JS, Ahn CW, Kim KR, Cha KR, Kim CH

  • KMID: 1512819
  • Korean J Psychopharmacol.
  • 2007 Mar;18(2):81-85.
OBJECTIVE: Patients with schizophrenia are at a higher risk for developing insulin resistance and type 2 diabetes mellitus (T2DM). However, few studies have examined abdominal fat and mid-thigh low-density muscle...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Body Weight Gain and Metabolic Changes in Patients with Schizophrenia during 12-Week Randomized Treatment of Ziprasidone and Risperidone

Ahn YM, Lee KY, Kim KS, Kim DK, Kim YH, Kim CY, Kim CE, Min S, Park MC, Shin YM, Cho HS, Kim YS

  • KMID: 1512821
  • Korean J Psychopharmacol.
  • 2007 Mar;18(2):92-102.
OBJECTIVE: Body weight gain and metabolic syndrome are frequent adverse side effects of atypical antipsychotics. However, ziprasidone has been reported to have less effect on body weight and other metabolic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr